Skip to main content
Livermore
Livermore
ZHEN

Bausch Health Companies Inc.

BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000885590

In the last 90 days, Bausch Health Companies Inc. insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $1.18B in total; no superinvestor holds it.

Superinvestors holding BHC, Q2 2026

See all superinvestors

No superinvestor reported holding BHC in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BHC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2026

    0 superinvestors holding at quarter end

    Sold out
    Oaktree Capital, Third Point

  2. Q4 2025

    2 superinvestors holding at quarter end

    Added
    Third Point (+250.0%)

  3. Q3 2025

    2 superinvestors holding at quarter end

    New
    Third Point
    Sold out
    Icahn Capital

  4. Q1 2025

    2 superinvestors holding at quarter end

    Sold out
    Elliott Investment Management

  5. Q4 2024

    3 superinvestors holding at quarter end

    Sold out
    Maverick Capital

  6. Q3 2024

    4 superinvestors holding at quarter end

    Added
    Maverick Capital (+17.7%)

  7. Q2 2024

    4 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    Oaktree Capital (−2.3%)
    Sold out
    Chou Associates

  8. Q4 2023

    4 superinvestors holding at quarter end

    Sold out
    Maverick Capital

  9. Q3 2023

    5 superinvestors holding at quarter end

    New
    Oaktree Capital, Maverick Capital

  10. Q2 2023

    3 superinvestors holding at quarter end

    Reduced
    Elliott Investment Management (−21.4%)

  11. Q4 2022

    3 superinvestors holding at quarter end

    Sold out
    Maverick Capital

  12. Q3 2022

    4 superinvestors holding at quarter end

    New
    Maverick Capital, Elliott Investment Management
    Sold out
    ValueAct Capital

  13. Q2 2022

    3 superinvestors holding at quarter end

    Reduced
    ValueAct Capital (−0.6%), Chou Associates (−6.5%)
    Sold out
    Maverick Capital

  14. Q1 2022

    4 superinvestors holding at quarter end

    Reduced
    ValueAct Capital (−7.6%)

  15. Q4 2021

    4 superinvestors holding at quarter end

    Added
    Icahn Capital (+1.8%)
    Reduced
    ValueAct Capital (−13.0%), Chou Associates (−48.8%), Maverick Capital (−87.4%)

  16. Q3 2021

    4 superinvestors holding at quarter end

    Added
    Maverick Capital (+1,002.9%)

  17. Q2 2021

    4 superinvestors holding at quarter end

    Reduced
    Maverick Capital (−12.6%)